# Evaluate Onset of Action of a Fast Release Aspirin

> **NCT01420094** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 510 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)
- **DRUG:** Acetaminophen (Tylenol extra strength)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01420094
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-16
- **Primary completion:** 2011-09-08
- **Final completion:** 2011-09-08
- **Target enrollment:** 510 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01420094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01420094, "Evaluate Onset of Action of a Fast Release Aspirin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01420094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*